# Sarepta Therapeutics, Inc.: Form SCHEDULE 13D, filed Feb 14, 2025

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: SCHEDULE 13D
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 17:23 ET
- Period: not reported
- Accession: 0000950170-25-021481
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000095017025021481/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000095017025021481/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000095017025021481/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-021481. Last ingested by Listed: Nov 10, 2026, 17:28 ET. No prices; not investment advice.